{"title":"Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study","authors":"Dao-Xing Deng, Mengzhu Shen, Xiaohui Zhang, Lanping Xu, Yu Wang, Chen‐hua Yan, Yuhong Chen, Huan Chen, W. Han, Feng‐rong Wang, Jing‐zhi Wang, Xiaojun Huang, X. Mo","doi":"10.59717/j.xinn-med.2023.100009","DOIUrl":null,"url":null,"abstract":"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a crucial curative method to treat hematologic malignancies and non-malignant hematologic disorder. 1,","PeriodicalId":423184,"journal":{"name":"The Innovation Medicine","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Innovation Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59717/j.xinn-med.2023.100009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a crucial curative method to treat hematologic malignancies and non-malignant hematologic disorder. 1,
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
